In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK)/c-ros oncogene···【more】
Release date:2026-01-23Recommended:354
Lorlatinib is a third-generation dual-target inhibitor of ALK/ROS1, primarily in···【more】
Release date:2026-01-23Recommended:300
The price of lorlatinib varies significantly, mainly depending on the drug sourc···【more】
Release date:2026-01-23Recommended:285
This drug is a prescription medicine. Its use must strictly follow the doctor’s ···【more】
Release date:2026-01-23Recommended:293
The price of Lorlatinib is subject to significant fluctuations due to the impact···【more】
Release date:2026-01-23Recommended:263
The monthly treatment cost of lorlatinib currently available in China fluctuates···【more】
Release date:2026-01-23Recommended:357
Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has a···【more】
Release date:2026-01-23Recommended:333
On March 3, 2021, Pfizer announced that the U.S. Food and Drug Administration (F···【more】
Release date:2026-01-23Recommended:365
At the Presidential Symposium of the 2020 ESMO Annual Congress, results of a hea···【more】
Release date:2026-01-23Recommended:267
In December 2020, the U.S. Food and Drug Administration (FDA) accepted a supplem···【more】
Release date:2026-01-23Recommended:345
Pfizer recently announced that the Phase III CROWN study, which evaluates Lorbre···【more】
Release date:2026-01-23Recommended:282
Lorbrena (generic name: Lorlatinib) is a next-generation tyrosine kinase inhibit···【more】
Release date:2026-01-23Recommended:322